@@ -2171,8 +2171,23 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
className={`px-4 py-2 text-sm font-medium border-b-2 transition-colors ${
activeTab === "info"
? "border-blue-500 text-blue-600"
- : "border-transparent text-muted-foreground hover:text-foreground"
+ : "border-transparent text-gray-600 dark:text-muted-foreground dark:hover:text-foreground dark:hover:bg-blue-900"
}`}
+ style={{
+ backgroundColor: activeTab === "info" ? undefined : "transparent"
+ }}
+ onMouseEnter={(e) => {
+ if (activeTab !== "info") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
+ onMouseLeave={(e) => {
+ if (activeTab !== "info") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
>
Informações
@@ -2183,8 +2198,23 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
className={`px-4 py-2 text-sm font-medium border-b-2 transition-colors ${
activeTab === "editor"
? "border-blue-500 text-blue-600"
- : "border-transparent text-muted-foreground hover:text-foreground"
+ : "border-transparent text-gray-600 dark:text-muted-foreground dark:hover:text-foreground dark:hover:bg-blue-900"
}`}
+ style={{
+ backgroundColor: activeTab === "editor" ? undefined : "transparent"
+ }}
+ onMouseEnter={(e) => {
+ if (activeTab !== "editor") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
+ onMouseLeave={(e) => {
+ if (activeTab !== "editor") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
>
Editor
@@ -2194,8 +2224,23 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
className={`px-4 py-2 text-sm font-medium border-b-2 transition-colors ${
activeTab === "imagens"
? "border-blue-500 text-blue-600"
- : "border-transparent text-muted-foreground hover:text-foreground"
+ : "border-transparent text-gray-600 dark:text-muted-foreground dark:hover:text-foreground dark:hover:bg-blue-900"
}`}
+ style={{
+ backgroundColor: activeTab === "imagens" ? undefined : "transparent"
+ }}
+ onMouseEnter={(e) => {
+ if (activeTab !== "imagens") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
+ onMouseLeave={(e) => {
+ if (activeTab !== "imagens") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
>
Imagens ({imagens.length})
@@ -2205,8 +2250,23 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
className={`px-4 py-2 text-sm font-medium border-b-2 transition-colors ${
activeTab === "campos"
? "border-blue-500 text-blue-600"
- : "border-transparent text-muted-foreground hover:text-foreground"
+ : "border-transparent text-gray-600 dark:text-muted-foreground dark:hover:text-foreground dark:hover:bg-blue-900"
}`}
+ style={{
+ backgroundColor: activeTab === "campos" ? undefined : "transparent"
+ }}
+ onMouseEnter={(e) => {
+ if (activeTab !== "campos") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
+ onMouseLeave={(e) => {
+ if (activeTab !== "campos") {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
>
Campos
@@ -2216,8 +2276,23 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
className={`px-4 py-2 text-sm font-medium border-b-2 transition-colors ${
showPreview
? "border-green-500 text-green-600"
- : "border-transparent text-muted-foreground hover:text-foreground"
+ : "border-transparent text-gray-600 dark:text-muted-foreground dark:hover:text-foreground dark:hover:bg-blue-900"
}`}
+ style={{
+ backgroundColor: !showPreview ? "transparent" : undefined
+ }}
+ onMouseEnter={(e) => {
+ if (!showPreview) {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
+ onMouseLeave={(e) => {
+ if (!showPreview) {
+ e.currentTarget.style.backgroundColor = "transparent";
+ e.currentTarget.style.color = "#4B5563";
+ }
+ }}
>
{showPreview ? "Ocultar" : "Pré-visualização"}
@@ -2270,7 +2345,7 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
Dados do Paciente
-
+
Nome: {pacienteSelecionado.nome}
@@ -2314,6 +2389,7 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
size="sm"
onClick={() => formatText("bold")}
title="Negrito"
+ className="hover:bg-blue-50 dark:hover:bg-accent"
>
B
@@ -2322,6 +2398,7 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
size="sm"
onClick={() => formatText("italic")}
title="Itálico"
+ className="hover:bg-blue-50 dark:hover:bg-accent"
>
I
@@ -2330,6 +2407,7 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
size="sm"
onClick={() => formatText("underline")}
title="Sublinhado"
+ className="hover:bg-blue-50 dark:hover:bg-accent"
>
U
@@ -2338,6 +2416,7 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
size="sm"
onClick={() => formatText("list")}
title="Lista"
+ className="hover:bg-blue-50 dark:hover:bg-accent"
>
•
@@ -2596,10 +2675,10 @@ Nevo melanocítico benigno. Seguimento clínico recomendado.
Este editor permite escrever relatórios de forma livre, com formatação de texto rica.
-